4front Ventures Corp Stock Working Capital

FFNTF Stock  USD 0.03  0.0003  0.94%   
4Front Ventures Corp fundamentals help investors to digest information that contributes to 4Front Ventures' financial success or failures. It also enables traders to predict the movement of 4Front OTC Stock. The fundamental analysis module provides a way to measure 4Front Ventures' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 4Front Ventures otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

4Front Ventures Corp OTC Stock Working Capital Analysis

4Front Ventures' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

 = 

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition

According to the company's disclosures, 4Front Ventures Corp has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The working capital for all United States stocks is 100.0% higher than that of the company.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

4Front Fundamentals

About 4Front Ventures Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze 4Front Ventures Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 4Front Ventures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 4Front Ventures Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in 4Front OTC Stock

4Front Ventures financial ratios help investors to determine whether 4Front OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 4Front with respect to the benefits of owning 4Front Ventures security.